TY - JOUR
TI - Lorlatinib for non-small cell lung cancer
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2020
ET - 2020/10/22
VL - 43
IS - 6
SP - 216
EP - 217
DO - 10.18773/austprescr.2020.065
LA - eng
UR - https://australianprescriber.tg.org.au/articles/lorlatinib-for-non-small-cell-lung-cancer.html
KW - lorlatinib
KW - non-small cell lung cancer
KW - Lorviqua
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -